United States Biotechnology & Medical Research

Arcutis Biotherapeutics Inc (ARQT)

Track

Over the past 90 days, Arcutis Biotherapeutics Inc. insiders have engaged in 15 transactions, all of which were sales totaling approximately $927,290. These activities involved multiple officers and directors, including Howard Welgus and Sue-Jean Lin. The selling activity follows the company's May 2026 results financiers, where the firm reported an earnings miss.
Ticker: ARQT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Arcutis Biotherapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 3 Aug 2026
Value US$1,374,542.44 | Price 97.96 | Shares 87,022 (-32.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-03 PlS Planned sale
2.5
Watanabe Todd

See Remarks

Executive Director
87,022 -32.2%
97.96
US$1,374,542 		87,022 -32.2% 97.96 US$1,374,542
2026-08-05 2026-08-03 S Sale
2.3
Burnett Patrick

See Remarks

Officer
73,794 -4.7%
292.57
US$2,253,488 		73,794 -4.7% 292.57 US$2,253,488
2026-08-05 2026-08-03 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
69,603 -16.8%
68.99
US$567,596 		69,603 -16.8% 68.99 US$567,596
2026-08-03 2026-08-03 PrS Proposed sale
3.1
Matsuda Masaru

Officer

Officer
1,000
26.12
US$100,000 		1,000 26.12 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.5
Todd Frank Watanabe

Officer

Officer
1,000
26.12
US$100,000 		1,000 26.12 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
1,000
26.12
US$100,000 		1,000 26.12 US$100,000
2026-07-17 2026-07-15 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
4,730 -11.3%
26.91
US$127,284 		4,730 -11.3% 26.91 US$127,284
2026-07-15 2026-07-15 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
4,730
26.91
US$127,284 		4,730 26.91 US$127,284
2026-06-17 2026-06-17 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
635 -1.7%
25.67
US$16,300 		635 -1.7% 25.67 US$16,300
2026-06-17 2026-06-17 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
635
25.67
US$16,300 		635 25.67 US$16,300
2026-06-17 2026-06-15 PlS Planned sale
3.1
LIN SUE-JEAN
Non-Executive Director
4,946 -15.2%
24.38
US$120,587 		4,946 -15.2% 24.38 US$120,587
2026-06-17 2026-06-15 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
4,096 -9.6%
24.41
US$99,980 		4,096 -9.6% 24.41 US$99,980
2026-06-15 2026-06-15 PrS Proposed sale
3.1
Sue-Jean Lin

Officer

Officer
4,946
24.38
US$120,587 		4,946 24.38 US$120,587
2026-06-15 2026-06-15 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
4,096
24.41
US$99,980 		4,096 24.41 US$99,980
2026-05-13 2026-05-11 S Sale
3.3
Vairavan Latha

SVP Chief Financial Officer

Officer
435 -0.5%
21.05
US$9,157 		435 -0.5% 21.05 US$9,157
2026-05-13 2026-05-11 S Sale
2.3
Burnett Patrick

See Remarks

Officer
222 -0.2%
21.05
US$4,673 		222 -0.2% 21.05 US$4,673
2026-05-11 2026-05-11 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
222
21.05
US$4,673 		222 21.05 US$4,673
2026-05-11 2026-05-11 PrS Proposed sale
3.3
Latha Vairavan

officer

Officer
435
21.05
US$9,157 		435 21.05 US$9,157
2026-05-06 2026-05-04 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
884 -0.7%
23.61
US$20,872 		884 -0.7% 23.61 US$20,872
2026-05-06 2026-05-04 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
7,372 -5.5%
23.27
US$171,543 		7,372 -5.5% 23.27 US$171,543
2026-05-06 2026-05-04 S Sale
2.3
Burnett Patrick

See Remarks

Officer
684 -0.6%
23.61
US$16,150 		684 -0.6% 23.61 US$16,150
2026-05-06 2026-05-04 S Sale
3.3
Vairavan Latha

SVP Chief Financial Officer

Officer
1,341 -1.5%
23.61
US$31,662 		1,341 -1.5% 23.61 US$31,662
2026-05-06 2026-05-04 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
3,172 -0.4%
23.61
US$74,893 		3,172 -0.4% 23.61 US$74,893
2026-05-04 2026-05-04 PrS Proposed sale
3.3
Latha Vairavan

Officer

Officer
1,341
23.61
US$31,662 		1,341 23.61 US$31,662
2026-05-04 2026-05-04 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
684
23.61
US$16,150 		684 23.61 US$16,150
2026-05-04 2026-05-04 PrS Proposed sale
2.5
Todd Watanabe

Officer

Officer
3,172
23.61
US$74,893 		3,172 23.61 US$74,893
2026-05-04 2026-05-04 PrS Proposed sale
3.1
Masaru Matsuda

officer

Officer
8,256
23.31
US$192,416 		8,256 23.31 US$192,416
2026-05-05 2026-05-01 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
7,144 -18.0%
22.99
US$164,220 		7,144 -18.0% 22.99 US$164,220
2026-05-01 2026-05-01 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
7,144
22.99
US$164,220 		7,144 22.99 US$164,220
2026-04-03 2026-04-01 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
10,000 -20.1%
23.88
US$238,801 		10,000 -20.1% 23.88 US$238,801
2026-04-01 2026-04-01 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
10,000
23.88
US$238,801 		10,000 23.88 US$238,801
2026-03-04 2026-03-02 PlS Planned sale
Leonard Keith R
Non-Executive Director
39,272 -64.0%
25.39
US$997,195 		39,272 -64.0% 25.39 US$997,195
2026-03-04 2026-03-02 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
10,000 -16.7%
25.65
US$256,518 		10,000 -16.7% 25.65 US$256,518
2026-03-03 2026-03-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
1,068 -0.1%
25.91
US$27,676 		1,068 -0.1% 25.91 US$27,676
2026-03-03 2026-03-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
36,281 -4.4%
25.16
US$912,852 		36,281 -4.4% 25.16 US$912,852
2026-03-03 2026-03-02 S Sale
2.5
Edwards Larry Todd

See Remarks

Officer
103 -0.1%
25.91
US$2,669 		103 -0.1% 25.91 US$2,669
2026-03-03 2026-03-02 S Sale
2.5
Edwards Larry Todd

See Remarks

Officer
3,584 -2.0%
25.16
US$90,177 		3,584 -2.0% 25.16 US$90,177
2026-03-03 2026-03-02 S Sale
2.3
Burnett Patrick

See Remarks

Officer
181 -0.1%
25.91
US$4,690 		181 -0.1% 25.91 US$4,690
2026-03-03 2026-03-02 S Sale
2.3
Burnett Patrick

See Remarks

Officer
6,106 -4.8%
25.16
US$153,629 		6,106 -4.8% 25.16 US$153,629
2026-03-03 2026-03-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
1,987 -1.4%
25.70
US$51,066 		1,987 -1.4% 25.70 US$51,066
2026-03-03 2026-03-02 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
193 -0.1%
25.91
US$5,001 		193 -0.1% 25.91 US$5,001
2026-03-03 2026-03-02 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
6,553 -4.6%
25.16
US$164,876 		6,553 -4.6% 25.16 US$164,876
2026-03-03 2026-03-02 S Sale
3.3
Vairavan Latha

SVP Chief Financial Officer

Officer
81 -0.1%
25.91
US$2,099 		81 -0.1% 25.91 US$2,099
2026-03-03 2026-03-02 S Sale
3.3
Vairavan Latha

SVP Chief Financial Officer

Officer
2,772 -3.1%
25.16
US$69,745 		2,772 -3.1% 25.16 US$69,745
2026-03-02 2026-03-02 PrS Proposed sale
3.1
Masaru Matsuda

officer

Officer
12,058
26.03
US$313,878 		12,058 26.03 US$313,878
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Larry Todd Edwards

Officer

Officer
3,687
25.18
US$92,846 		3,687 25.18 US$92,846
2026-03-02 2026-03-02 PrS Proposed sale
3.3
Latha Vairavan

officer

Officer
2,853
25.18
US$71,845 		2,853 25.18 US$71,845
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Todd Watanabe

Officer

Officer
37,349
25.18
US$940,526 		37,349 25.18 US$940,526
2026-03-02 2026-03-02 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
6,287
25.18
US$158,320 		6,287 25.18 US$158,320
2026-03-02 2026-03-02 PrS Proposed sale
Keith Leonard

Board of Director

Non-Executive Director
39,272
25.39
US$997,195 		39,272 25.39 US$997,195
2026-03-02 2026-03-02 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
10,000
25.65
US$256,518 		10,000 25.65 US$256,518
2026-03-03 2026-02-27 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
3,325 -2.3%
27.95
US$92,934 		3,325 -2.3% 27.95 US$92,934
2026-02-04 2026-02-04 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
9,794 -10.8%
25.81
US$252,748 		9,794 -10.8% 25.81 US$252,748
2026-02-04 2026-02-04 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
9,794 -10.8%
25.81
US$252,748 		9,794 -10.8% 25.81 US$252,748
2026-02-04 2026-02-04 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
9,794
25.81
US$252,748 		9,794 25.81 US$252,748
2026-02-04 2026-02-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
4,714 -4.1%
25.63
US$120,820 		4,714 -4.1% 25.63 US$120,820
2026-02-04 2026-02-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
19,379 -14.5%
25.24
US$489,126 		19,379 -14.5% 25.24 US$489,126
2026-02-04 2026-02-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
8,562 -6.0%
24.97
US$213,793 		8,562 -6.0% 24.97 US$213,793
2026-02-04 2026-02-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
4,714 -4.1%
25.63
US$120,820 		4,714 -4.1% 25.63 US$120,820
2026-02-04 2026-02-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
19,379 -14.5%
25.24
US$489,126 		19,379 -14.5% 25.24 US$489,126
2026-02-04 2026-02-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
8,562 -6.0%
24.97
US$213,793 		8,562 -6.0% 24.97 US$213,793
2026-02-04 2026-02-02 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
7,983 -5.3%
25.50
US$203,554 		7,983 -5.3% 25.50 US$203,554
2026-02-04 2026-02-02 S Sale
2.3
Burnett Patrick

See Remarks

Officer
3,675 -3.9%
25.50
US$93,707 		3,675 -3.9% 25.50 US$93,707
2026-02-04 2026-02-02 PlS Planned sale
1.6
Welgus Howard G.
Non-Executive Director
10,000 -14.3%
25.05
US$250,483 		10,000 -14.3% 25.05 US$250,483
2026-02-04 2026-02-02 PlS Planned sale
2.5
Edwards Larry Todd

See Remarks

Officer
2,052 -1.4%
25.50
US$52,323 		2,052 -1.4% 25.50 US$52,323
2026-02-04 2026-02-02 S Sale
3.3
Vairavan Latha

SVP Chief Financial Officer

Officer
1,320 -2.0%
25.50
US$33,658 		1,320 -2.0% 25.50 US$33,658
2026-02-04 2026-02-02 PlS Planned sale
2.5
Watanabe Todd

See Remarks

Executive Director
19,833 -2.7%
25.50
US$505,710 		19,833 -2.7% 25.50 US$505,710
2026-02-02 2026-02-02 PrS Proposed sale
3.1
Masaru Matsuda

officer

Officer
40,638
25.28
US$1,027,275 		40,638 25.28 US$1,027,275
2026-02-02 2026-02-02 PrS Proposed sale
2.5
Todd Edwards

Officer

Officer
2,052
25.50
US$52,323 		2,052 25.50 US$52,323
2026-02-02 2026-02-02 PrS Proposed sale
3.3
Latha Vairavan

Officer

Officer
1,320
25.50
US$33,658 		1,320 25.50 US$33,658
2026-02-02 2026-02-02 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
3,675
25.50
US$93,707 		3,675 25.50 US$93,707
2026-02-02 2026-02-02 PrS Proposed sale
2.5
Todd Frank Watanabe

officer

Officer
19,833
25.50
US$505,710 		19,833 25.50 US$505,710
2026-02-02 2026-02-02 PrS Proposed sale
1.6
Howard Welgus

Director

Non-Executive Director
10,000
25.05
US$250,483 		10,000 25.05 US$250,483
2026-01-07 2026-01-05 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
2,490 -2.6%
28.98
US$72,166 		2,490 -2.6% 28.98 US$72,166
2026-01-05 2026-01-05 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
2,490
28.98
US$72,166 		2,490 28.98 US$72,166
Explore more

More insider trading research around Arcutis Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America